Logo image of FME.DE

FRESENIUS MEDICAL CARE AG (FME.DE) Stock Price, Quote, News and Overview

FRA:FME - Deutsche Boerse Ag - DE0005785802 - Common Stock - Currency: EUR

45.16  +0.94 (+2.13%)

FME.DE Quote, Performance and Key Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (2/26/2025, 3:00:19 PM)

45.16

+0.94 (+2.13%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High48.31
52 Week Low32.51
Market Cap26.50B
Shares586.83M
Float398.06M
Yearly Dividend1.12
Dividend Yield2.71%
PE16.13
Fwd PE12.83
Earnings (Next)02-25 2025-02-25/amc
IPO10-02 1996-10-02


FME.DE short term performance overview.The bars show the price performance of FME.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20

FME.DE long term performance overview.The bars show the price performance of FME.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 20 -20

The current stock price of FME.DE is 45.16 EUR. In the past month the price decreased by -5.99%. In the past year, price increased by 24.11%.

FRESENIUS MEDICAL CARE AG / FME Daily stock chart

FME.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
1CVS.MI CVS HEALTH CORP 11.73 76.15B
CVS.DE CVS HEALTH CORP 11.67 75.81B
FRE.DE FRESENIUS SE & CO KGAA 36.16 21.99B
V3V.DE FAMICORD AG 29.86 73.74M

About FME.DE

Company Profile

FME logo image Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 113,079 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The firm also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The firm supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Company Info

FRESENIUS MEDICAL CARE AG

Else-Kroener-Strasse 1

Bad Homburg vor der Hohe HESSEN DE

Employees: 113639

Company Website: https://www.freseniusmedicalcare.com/

Investor Relations: https://www.freseniusmedicalcare.com/en/investors/investors-overview/

Phone: 4961726090

FRESENIUS MEDICAL CARE AG / FME.DE FAQ

What is the stock price of FRESENIUS MEDICAL CARE AG today?

The current stock price of FME.DE is 45.16 EUR. The price increased by 2.13% in the last trading session.


What is the ticker symbol for FRESENIUS MEDICAL CARE AG stock?

The exchange symbol of FRESENIUS MEDICAL CARE AG is FME and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is FME.DE stock listed?

FME.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for FRESENIUS MEDICAL CARE AG stock?

28 analysts have analysed FME.DE and the average price target is 44.69 EUR. This implies a price decrease of -1.03% is expected in the next year compared to the current price of 45.16. Check the FRESENIUS MEDICAL CARE AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is FRESENIUS MEDICAL CARE AG worth?

FRESENIUS MEDICAL CARE AG (FME.DE) has a market capitalization of 26.50B EUR. This makes FME.DE a Large Cap stock.


How many employees does FRESENIUS MEDICAL CARE AG have?

FRESENIUS MEDICAL CARE AG (FME.DE) currently has 113639 employees.


What are the support and resistance levels for FRESENIUS MEDICAL CARE AG (FME.DE) stock?

FRESENIUS MEDICAL CARE AG (FME.DE) has a support level at 44.21 and a resistance level at 44.24. Check the full technical report for a detailed analysis of FME.DE support and resistance levels.


Is FRESENIUS MEDICAL CARE AG (FME.DE) expected to grow?

The Revenue of FRESENIUS MEDICAL CARE AG (FME.DE) is expected to decline by -0.64% in the next year. Check the estimates tab for more information on the FME.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy FRESENIUS MEDICAL CARE AG (FME.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does FRESENIUS MEDICAL CARE AG (FME.DE) stock pay dividends?

FRESENIUS MEDICAL CARE AG (FME.DE) has a dividend yield of 2.71%. The yearly dividend amount is currently 1.12. Check the full fundamental report for a detailed analysis of FME.DE dividend history, reliability and sustainability.


When does FRESENIUS MEDICAL CARE AG (FME.DE) report earnings?

FRESENIUS MEDICAL CARE AG (FME.DE) will report earnings on 2025-02-25, after the market close.


What is the Price/Earnings (PE) ratio of FRESENIUS MEDICAL CARE AG (FME.DE)?

The PE ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 16.13. This is based on the reported non-GAAP earnings per share of 2.8 and the current share price of 45.16 EUR. Check the full fundamental report for a full analysis of the valuation metrics for FME.DE.


FME.DE Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to FME.DE. When comparing the yearly performance of all stocks, FME.DE is one of the better performing stocks in the market, outperforming 83.83% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FME.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE. Both the profitability and the financial health of FME.DE get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FME.DE Financial Highlights

Over the last trailing twelve months FME.DE reported a non-GAAP Earnings per Share(EPS) of 2.8. The EPS increased by 9.03% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.43%
ROA 2.03%
ROE 4.84%
Debt/Equity 0.71
Chartmill High Growth Momentum
EPS Q2Q%-48%
Sales Q2Q%3.67%
EPS 1Y (TTM)9.03%
Revenue 1Y (TTM)0.29%

FME.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 55% to FME.DE. The Buy consensus is the average rating of analysts ratings from 28 analysts.

For the next year, analysts expect an EPS growth of 12.81% and a revenue growth -0.64% for FME.DE


Ownership
Inst Owners36.63%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts55
Price Target44.69 (-1.04%)
EPS Next Y12.81%
Revenue Next Year-0.64%